|
|
|
|
| LEADER |
01067nam a2200301 4500 |
| 001 |
PPN120446987 |
| 005 |
20210429055700.0 |
| 010 |
|
|
|a 0-8493-2706-7
|b rel.
|
| 010 |
|
|
|a 978-0-8493-2706-3
|b rel.
|
| 100 |
|
|
|a 20080109d2006 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a US
|
| 105 |
|
|
|a a ||||001yy
|
| 106 |
|
|
|a r
|
| 200 |
0 |
|
|a Excipient development for pharmaceutical, biotechnology, and drug delivery systems
|b Texte imprimé
|f edited by Ashok Katdare, ..., Mahesh V. Chaubal, ...
|
| 210 |
|
|
|a New York
|c Informa Healthcare
|d cop. 2006
|
| 215 |
|
|
|a 1 vol. (xvii- 452 p.)
|c ill.
|d 27 cm
|
| 320 |
|
|
|a Notes bibliographiques et index
|
| 606 |
|
|
|3 PPN050244698
|a Excipients
|2 rameau
|
| 606 |
|
|
|3 PPN077071859
|a Autorisations de mise sur le marché
|2 rameau
|
| 676 |
|
|
|a 615/.19
|v 22
|
| 686 |
|
|
|a QV 800
|b E955 2006
|2 usnlm
|
| 702 |
|
1 |
|3 PPN120445891
|a Katdare
|b Ashok
|4 340
|
| 702 |
|
1 |
|3 PPN120446030
|a Chaubal
|b Mahesh Vijay
|4 340
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20080109
|g AFNOR
|
| 930 |
|
|
|5 441092101:324340966
|b 441092101
|a QV 800 EXC
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 510819
|
Nantilus
